About this trial
Lung cancer screening (LCS) can reduce lung cancer-related mortality by 20%, but only 5-10% of eligible individuals have received an initial LCS. The goal of this study is to partner with community stakeholders to jointly develop and pilot test a multi-component community health worker-delivered intervention targeting key barriers to improve LCS and tobacco treatment utilization. The proposed activities will lay the groundwork for a subsequent R01 grant, conducting a fully powered randomized clinical trial to establish CHWs as an evidence-based practice that will facilitate access to screening and tobacco treatment, to reduce lung cancer mortality.
Eligibility criteria
Qualifiers
Adults between the age of 50 and 80.
Potentially eligible for LCS according to the Electronic Health Record smoking history.
Receive their primary care at Mason Square, High Street, or Brightwood community health centers.
English- or Spanish- speaking.
Disqualifiers
Not eligible for lung cancer screening based on age (age < 50 or > 80 years) or smoking history (has not smoked more than 20 pack-years of tobacco cigarettes or quit more than 15 years ago).
Have received a lung cancer screen in the past.
Trial design
Treatments tested in this trial
- Community health worker delivered outreach, shared decision-making, tobacco treatment, and navigation
- Enhanced Usual Care
Treatment groups
Locations
Sponsors and collaborators
Baystate Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator